A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednisone per local regulation.
Epistemonikos ID: 2686d36737ec4a6bf9b9b2a532815445b14dfa0f
First added on: May 21, 2024